Descriptive Analysis of Patients Treated with Diroximel Fumarate and Dimethyl Fumarate—A Real-Life Experience
Our real-life analysis of patients treated with DMF or DRF supports several studies' findings regarding decreased GI side effects with DRF vs. DMF without decreasing efficacy. However, our data show a greater reduction in lymphocytes in patients with DRF compared to DMF, so more studies are necessary.
Authors
- Marina Blanco‐Ruiz
- Francisco José García‐Peñalvo (ORCID: https://orcid.org/0000-0001-9987-5584)
- Emilio Molina-Cuadrado (ORCID: https://orcid.org/0000-0002-8944-2504)
- María Luisa Ruiz-Franco (ORCID: https://orcid.org/0000-0003-4338-8167)
- Carmen Muñoz Fernández (ORCID: https://orcid.org/0009-0005-2887-9189)
- Belén Sánchez-Rodríguez
Institutions
- Complejo Hospitalario Torrecárdenas (ES)
Publication Details
- Journal
- Journal of Personalized Medicine
- Published
- 2024-12-31
- DOI
- https://doi.org/10.3390/jpm15010012
- Citations
- 1
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.42